Continuum Advisory’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$508K Buy
1,547
+176
+13% +$63.2K 0.05% 280
2025
Q4
$482K Buy
1,371
+757
+123% +$276K 0.05% 285
2025
Q3
$227K Buy
+614
New +$237K 0.02% 405
2025
Q2
Sell
-532
Closed -$198K 1431
2025
Q1
$198K Buy
532
+29
+6% +$11K 0.03% 392
2024
Q4
$181K Buy
503
+47
+10% +$17.4K 0.02% 402
2024
Q3
$175K Buy
456
+345
+311% +$119K 0.02% 419
2024
Q2
$37.8K Sell
111
-7
-6% -$2.37K 0.01% 660
2024
Q1
$39K Buy
+118
New +$39.7K 0.01% 648

Other funds holding SYK

Continuum Advisory's SYK Position: Q1 2026 in Review

Continuum Advisory increased its Stryker (SYK) stake by 13% in Q1 2026, buying an estimated $63.2K and bringing the position to 1,547 shares worth $508K. The position accounts for 0.05% of the portfolio, ranked #280.

Continuum Advisory first reported a position in SYK in Q1 2024 and has held it in 8 quarters since. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Continuum Advisory held 1,547 shares of Stryker worth $508K as of Q1 2026.
  • Continuum Advisory bought 176 Stryker shares in Q1 2026, an estimated $63.2K.
  • Stryker made up 0.05% of Continuum Advisory's portfolio in Q1 2026, its #280 holding.
  • Continuum Advisory first reported a position in Stryker in Q1 2024 and has held it in 8 quarters since.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Continuum Advisory's 13F filing for Q1 2026, filed 22 Apr 2026.